Gregory Behar's most recent trade in Seres Therapeutics Inc was a trade of 35,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 22, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics Inc | Gregory Behar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
Axcella Health Inc | Gregory Behar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Seres Therapeutics Inc | Gregory Behar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Axcella Health Inc | Gregory Behar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) |